metaPreg - Terconazole during pregnancy

Terconazole updated on 01-29-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
Ano-rectal atresia and stenosis	1.76 [0.10, 31.33]	-	1 study	209	6	not evaluable	ROB	-
Cleft lip with or without cleft palate	1.47 [0.30, 7.27]	-	1 study	1,086	8	not evaluable	ROB	-
Congenital heart defects	1.04 [0.29, 3.70]	-	1 study	3,049	10	not evaluable	ROB	-
Craniosynostosis	0.82 [0.05, 14.60]	-	1 study	447	6	not evaluable	ROB	-
Diaphragmatic hernia	1.34 [0.08, 23.78]	-	1 study	275	6	not evaluable	ROB	-
Gastroschisis	0.81 [0.05, 14.35]	-	1 study	455	6	not evaluable	ROB	-
Hypospadias	1.03 [0.12, 8.53]	-	1 study	776	7	not evaluable	ROB	-
Neural Tube Defects	0.49 [0.03, 8.69]	-	1 study	750	6	not evaluable	ROB	-
Hide endpoints reported in only one study ...